|
 
- 积分
- 3495
- 威望
- 3495
- 包包
- 4879
|
美国冷泉港和国际干细胞协会（ISSCR）联合举办的细胞编程和重编程会议（Joint CSH Asia/ISSCR Conference on Cellular Programs & Reprogramming），于2011-10-24晚到2011-10-28中午结束，共开了3天半。来自世界各地的46个演讲者，围绕以下范围：1.Human Stem Cells; 2.Control of Pluripotency; 3.Differentiation Mechanisms; 4..Cell Interactions; 5.Molecular Control; 6.Cell Lineage; 7.Cell Therapies. 进行演讲。只采取全体大会演讲的形式，没有分会场交流。全体参会人数约430人，国内参会者应在一半以上。8 p& @) c3 Q5 @, k
' c) z e, T8 Q7 u3 o2 H% r
几点参会评论：
. f. ~3 T0 d9 g# q$ a8 D% o4 h1.本次会议演讲范围较广，主要是干细胞的基础演讲，大概2个演讲者提到干细胞临床治疗，因此对临床医师受益有限。
; ^) E0 ?+ l- E+ f/ ?5 [8 Q( v2.许多国际著名干细胞领域权威给予精彩演讲，且绝大部分演讲内容未发表，但视乎没有让人感觉“耳目一新、眼前一亮”的报告。; x2 o+ J" X b( T& B) p8 g, N
3.国内干细胞大牛仅裴端卿、邓宏魁参会（小牛惠立建也给talk），这样的干细胞国际盛会，又是在中国举办，国内其他干细胞大牛到了哪里？为什么不参会？我非常想见到国内权威能向国际权威提几个精彩的问题，并进行辩论，但可惜没看到，只是邓宏魁、惠立建各提了一个基本的问题。国内研究生参会较多，且提问较积极，虽然问题较基本、英文发音不准，但不怯场，值得表扬。
1 S* a, t* j& J. |; z8 n% { y# I% ?4.国际大佬基本上天天参会，较容易见到，也愿意回答问题，如国际皮肤干细胞的权威Elaine Fuchs教授，经常提问题，也天天被学生包围，不像国内某些大佬，一演讲完就找不到人了，像是怕见人。; {8 c0 o/ e- X
5.大家几乎一致认为会议组织的很好，住宿条件非常好，5星级宾馆，宾馆周围环境非常优美。会议伙食也非常好，已听到多人抱怨说吃胖了，回去要减肥。本人多次在国外参加ISSCR组织的年会，不得不说这是吃得最好的一次。会议结束前晚组织的具有苏州特色的文艺表演，让一些国外参会者看的眼都直了。
) P$ S0 n" Q, u
* m1 E) e) u' t1 {8 X/ F& M; S大会演讲嘉宾有：( e) ]2 a! U+ Y5 J! ?
1.Monday, October 240 R: ]4 p7 k/ |+ l# ~5 C
Welcome and Overview 9 s/ ^5 g/ U9 V( ]3 p5 }# T
Chairperson: Ronald D. McKay, PhD8 I& [2 d3 j! f& E
( j" `; D3 ]( w" z C5 l$ J
Opening Keynote: Elaine Fuchs, PhD, The Rockefeller University, USA + B( w5 _' {2 x) H3 \
9 O4 }3 X- ?9 ~- b
2.Tuesday, October 25 Session I: Human Stem Cells2 f2 o' p3 J# u
Chairperson: Hongkui Deng, PhD; y G2 h0 W- q9 l( L0 a3 }
" d- G7 V# H! L( r2 ?7 P
Fred Gage, PhD, Salk Institute for Biological Studies, USA * K! s6 o( F. L# {8 K: g: j
Esther Y. Son, Howard University
8 x; n9 M- f1 U% n$ EGong Chen, Pensylvania state University,
. g& f" S( J2 u6 GWolf Reik, MD, PhD, The Babraham Institute, United Kingdom $ b- n4 N) O- Z. ?: ?) B8 i. [' }
Linzhao Cheng, PhD, Johns Hopkins University, USA ; z4 ]5 {; n: Y3 C
Meng Li, Imperial College London- c* i2 a' T4 z6 o; o1 e& f
Joan Li, University of Gueensland+ K- I7 t6 k9 s* f$ U2 j! g9 u$ a1 ]
Richard A. Young, PhD, Whitehead Institute/M.I.T., USA9 A }1 M$ a! R: p. s* M# N
8 P; l& v! D& i4 U1 D5 l1 y' @3.Session II: Control of Pluripotency! C! x& w4 a: x& f! z
Chairperson: Hongkui Deng, PhD
q6 A! ?; u/ r" }( i$ V, Y8 a. k! u/ ^ l0 n5 P! m
Marius Wernig, MD, Stem Cell Institute, Stanford University, USA; r& j7 b9 ` }# i
Wenyu Zhou, University of Washington0 z J3 q, j' i6 d9 A& A3 L& Q
Shuibing Chen, Weill Cornell Medical College
# F3 I9 R- c7 u; L" k+ Z' ~Jennifer Nichols, PhD, Cambridge Stem Cell Initiative, University of Cambridge, UK
6 y: q( e1 q5 K, R6 G; I" c# k! ZYi Zhang, PhD, University of North Carolina, USA( R: y+ Y- U8 K
Alice E. Chen, Stemgene Inc., Cambage4 \6 k8 d) w+ y
Hitoshi Niwa, MD, PhD, Riken Center for Developmental Biology, Japan / O, g9 i6 S/ c1 p' u4 H
6 B* f' }7 g1 B$ v( m9 f" i
4.Session III: Poster presentations with refreshments
' |/ x: d5 U4 P4 Y4 P
5 |: Q5 R& s! C) v5 B- M5. Wednesday, October 26 Session IV: Differentiation Mechanisms
- m) w9 K/ h$ l- ZChairperson: V. Narry Kim, DPhill6 }, B9 A7 V* ]/ P5 F% s
" a% a' d9 o; z6 r7 m: `1 \3 xDuanqing Pei, PhD, Guangzhou Institute of Biomedicine and Health, China 6 Q. X( T3 _% n
Feng Ma, CAMC,( o: V" X9 x$ F- B3 z _1 `
Eric Deneault, University of Montreal,+ w5 J. B5 g8 B9 y. e) u( c1 O* N
Hongkui Deng, PhD, Peking University, China
$ w* y m+ ^6 \) BDeepak Srivastava, MD, Gladstone Institute of Cardiovascular Disease, USA# l; B& J5 Z' F3 p- |1 C
Lijian HUI, Shanghai,
# X+ s0 J/ `- vFiona Watt, DPhil, Cancer Research UK Cambridge Research Institute, United Kingdom
4 V7 b/ a/ T! W4 Y3 r$ \ ~0 J9 W' q' J0 O
6.Session V: Cell Interactions
) _0 p5 Z. Y- @" |& f7 TChairperson: V. Narry Kim, DPhill4 ^( H7 o0 B! S; @
. C/ W$ v; L7 d% [7 ?: [
Linheng Li, PhD, Stowers Institute for Medical Research, USA 6 A1 j- f3 N+ N; _1 |4 @( e1 P" n# A
Feng Liu, Zoology of China
0 e+ j& @3 d4 O( z; gHiromitsu Nakauchi, MD, PhD, Institute of Medical Science, University of Tokyo, Japan
6 W' f+ q" B. N' R/ sToshio Suda, MD, Keio University School of Medicine, Japan
( F. k, I' N0 }& {* sGuoping Fan, UCLA
" X- j% N, ?$ z- K1 ZHideyuki Okano, MD, PhD, Keio University School of Medicine, Japan # ?! `$ Y4 H% q* e0 r# j4 e: f
& k, q7 } A4 {) p! K7 i9 m( x0 O- K: Z
7. Thursday, October 27
2 i" L8 s3 ]; x7 w# @( @- gSession VI: Molecular Control
! a7 f. b+ O; ^/ q3 HChairperson: Richard A. Young, PhD+ z3 Y: y% ]3 r6 C8 g
; ~% e% f' d" y. `& V1 G+ _! L
Joanna Wysocka, PhD, Stanford University, USA
, L) S0 H# [8 J- @Lin He, UC Berkeley
6 }3 L& }9 v% [. q6 n- l: @# s' P4 uAndrew Xiao, Yale University' J2 i6 n4 ]$ c4 h. A) b0 t0 d
V. Narry Kim, DPhil, Seoul National University, Korea8 [* b: F `/ S* M$ \# ^9 D
Yukiko Gotoh, PhD, University of Tokyo, Japan
+ P, _; e, c. U3 G5 YGang Wang, CAS, China' L6 O( ?, \, Q, U5 S$ P
Shengxi Guan, New England Biolab) P) a: {! P* f+ ]5 J* y3 i
Zhaoyu Lin, Nanjing University4 _) U, w& @; r; J! y
Haifan Lin, PhD, Yale University School of Medicine, USA) X& s: x: q: Q( f
& j4 O* S0 E6 n6 Q
8.Session VII: Cell Lineage
! n# L1 A- s5 b% U2 U8 A, @Chairperson: Richard A. Young, PhD
, i: n& u! X8 X1 y* R. }0 j; d- Y# l1 k: L1 k+ q, w9 b
Anna-Katerina Hadjantonakis, MD, Memorial Sloan-Kettering Cancer Center, USA
0 u+ b4 ~1 |8 A% u/ d- R4 gLing-Ling Chen, PhD, Shanghai Institute for Biological Sciences, China9 Q) r8 H5 }; }; K. v3 i
Mark Krasnow, MD, PhD, Stanford University School of Medicine, USA! c* ]3 l: q+ k# v. Z) v
Ricardo A. Rossello, Howard Medical School
" K* w1 f! Q V0 {" d' ~8 o! oSheng Ding, Gladstone Institute, UCSF7 A- u7 j! J6 b
7 V& `( m+ f5 T# j/ j. S& W9.Friday, October 28 Closing Session: Cell Therapies
5 x( F# I ?* o" C8 {$ c, O7 c* JChairperson and closing remarks: Ronald D. McKay, PhD
7 S% W3 l, Y7 z0 J; P1 t7 V4 @* o- |- Q$ Q0 V& T/ e" s$ I
Lorenz Studer, MD, PhD, Memorial Sloan Kettering Cancer Center, USA6 n( W3 o3 f; a% r
Kevin A. D'Amour, PhD, ViaCyte, Inc., USA2 b4 w, w3 ]+ e4 M$ z' n
Tariq Enver, The Weatherall Institute of Molecular Medicine, UK , K1 i9 O1 P! D# p3 }1 B
9 }5 Y9 q( d/ x o GClosing Keynote: Gordon M. Keller, PhD, McEwen Center for Regenerative Medicine Ontario Cancer Institute, Canada( ?- N) Q, @1 q* ?6 T
/ z( y# o# L( M' j
会场照片
8 G6 t" v8 P( e3 Q; T0 |/ R- u. t6 D& }/ v9 u, _
. j1 Y! J" w% V3 {9 ~: i |
-
总评分: 威望 + 110
包包 + 220
查看全部评分
|
发表于 2011-10-31 20:02
发表于 2011-11-1 01:03
